Name: Ondero-D Tablet (Dapagliflozin/Linagliptin)
SKU: ZD-552
Availability: InStock

Ondero-D Tablet (Dapagliflozin/Linagliptin)

Ondero-D Tablet combines Dapagliflozin and Linagliptin to control blood sugar in Type 2 Diabetes. It lowers HbA1c, reduces kidney glucose reabsorption, and boosts insulin function. This once-daily medicine helps improve diabetes management when used with a healthy diet and exercise plan. Backed by trusted health authorities like Mayo Clinic, FDA, and WebMD, Ondero-D ensures effective glucose regulation with a proven safety profile. Always follow your doctor’s prescription and monitor for common side effects like urinary tract infections, increased urination, and mild hypoglycemia.

Strength, Size

Choose an option / Choose an option

Add to cart

Buy Now

SKU: ZD-552 Category: DIABETES

Ondero-D Tablet for Diabetes is a dual-action treatment combining Dapagliflozin and Linagliptin, designed to improve blood sugar control in adults with Type 2 Diabetes Mellitus. It helps lower HbA1c levels, reduces glucose reabsorption in the kidneys, and improves insulin function. According to Mayo Clinic, SGLT2 and DPP-4 inhibitors are widely prescribed for diabetes management. Learn more about blood sugar medicines at Drugs.com and WebMD.

For related products, visit our Diabetes Care Medicines section.

Key Benefits & Uses of Ondero-D Tablet for Diabetes

Maintains healthy blood glucose levels in Type 2 Diabetes.
Lowers HbA1c and reduces long-term complications.
Supports kidney health by limiting glucose reabsorption.
Enhances insulin production and sensitivity.
May contribute to weight management.

Explore more about diabetes treatment options at Healthline and PubMed.

How to Use Ondero-D Tablet

Take once daily, with or without food, as directed by your doctor.
Swallow whole with water.
Combine with a balanced diet and exercise plan for best results.

Find additional guidance in the FDA prescribing information.

Safety Information

Not for Type 1 Diabetes or ketoacidosis.
Use cautiously if you have kidney or liver disease.
Inform your doctor if pregnant or breastfeeding.
Regular monitoring of blood sugar and kidney function is recommended.

See WHO for global diabetes safety guidelines.

Possible Side Effects

Urinary tract infections
Frequent urination
Headache, cough, sore throat
Low blood sugar (when combined with insulin or sulfonylureas)

Seek medical attention if you develop persistent infections or dehydration.

Why Choose Ondero-D Tablet?

With its dual mechanism, Ondero-D Tablet (Dapagliflozin/Linagliptin) provides comprehensive control for Type 2 Diabetes. It reduces glucose at the kidney level while boosting insulin effectiveness, offering better balance and convenience with once-daily dosing. Endorsed by global health sources such as Mayo Clinic and FDA, Ondero-D is a trusted choice for long-term diabetes management.